LGALS3BP and metabolic dysfunction-associated steatohepatitis: We previously measured serum M2BP levels in 512 biopsy-proven NAFLD patients, and set a cut-off value (1.80 μg/mL) for the diagnosis of NASH from NAFLD [28].